The Emergence of Escape Mutations in COVID-19 Following Anti-Spike Monoclonal Antibody Treatment: How Do We Tackle It? [PDF]
Daniele Focosi,1 Massimo Franchini,2 Fabrizio Maggi,3 Arturo Casadevall4 1North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy; 2Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantua, Italy; 3Laboratory of ...
Focosi D +3 more
doaj +2 more sources
Wikipedia (and his brothers) to network and improve services
Only five years ago, the Italian librarians, archivists and museologists where both curious about and skeptical in order to collaborate, as knowledge organization professionals, with Wikipedia. However, nowadays there are many initiatives and projects in
Silvia Bruni +4 more
doaj +6 more sources
Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy. [PDF]
Focosi D, Maggi F.
europepmc +1 more source
Monitoring Appropriate Monoclonal Antibodies Prescribing via Administrative Data: An Application to Psoriasis. [PDF]
Guidotti E +4 more
europepmc +1 more source
Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines. [PDF]
Focosi D +4 more
europepmc +1 more source
SARS-CoV-2: Advances in Serological Methods and the Understanding of Antibody Escape. [PDF]
Focosi D, Maggi F.
europepmc +1 more source
SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern. [PDF]
Casadevall A, Focosi D.
europepmc +1 more source
A Web Tool to Estimate Baseline Anti-Spike Monoclonal Antibody Efficacy Based on Regional Genomic Surveillance. [PDF]
Focosi D.
europepmc +1 more source
The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review. [PDF]
Franchini M, Focosi D.
europepmc +1 more source
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients? [PDF]
Franchini M +3 more
europepmc +1 more source

